Summary: In Psychology Today, Andrew Penn, RN, MS, NP, a MAPS-sponsored therapist for Phase 3 clinical trials of MDMA-assisted psychotherapy for PTSD, outlines educational programs to consider when preparing for a future career as a psychedelic therapist. “In this heady time, we are building the plane as we are flying it. It’s with that caveat that I will discuss a handful of these programs,” says Penn.
Originally appearing here.
